logo
logo
Sign in

Moderna says its Covid-19 shot remains 93% effective 4-6 months after second dose

avatar
bohomak
Moderna says its Covid-19 shot remains 93% effective 4-6 months after second dose

However, it said it still expects booster shots to be necessary ahead of the winter season as antibody levels are expected to wane. It and rivals Pfizer and BioNTech have been advocating a third shot to maintain a high level of protection against Covid-19.

During a second-quarter earnings call, Moderna CEO Stephane Bancel said that the company would not produce more than the 800 million to 1 billion doses of the vaccine that it has targeted this year.

“We are now capacity constrained for 2021, and we are not taking any more orders for 2021 delivery,” he said.

Moderna shares fell 3.6 per cent to around US$403.87 (S$545) in pre-market trading after closing at US$419.05 on Wednesday.

That compares favourably with data released by rivals Pfizer and BioNTech last week in which they suggested their vaccine's efficacy waned around 6 per cent every two months, declining to around 84 per cent six months after the second shot.

 
 
 

Both the Moderna and Pfizer-BioNTech vaccines are based on messenger RNA (mRNA) technology. 실시간바카라

"Our Covid-19 vaccine is showing durable efficacy of 93 per cent through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant,” Moderna chief executive Bancel said.

The comment comes as public health officials across the world debate over whether additional doses are safe, effective and necessary even as they grapple with the fast-spreading Delta variant of the coronavirus.

collect
0
avatar
bohomak
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more